INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,781,833 | -66.7% | 87,977 | -57.1% | 0.00% | -66.7% |
| Q2 2023 | $8,353,335 | +365.0% | 204,839 | +325.0% | 0.00% | +200.0% |
| Q1 2023 | $1,796,451 | -15.6% | 48,201 | -21.0% | 0.00% | 0.0% |
| Q4 2022 | $2,129,092 | +23.0% | 61,023 | +97.3% | 0.00% | 0.0% |
| Q3 2022 | $1,731,000 | -16.5% | 30,931 | -22.8% | 0.00% | 0.0% |
| Q2 2022 | $2,073,000 | -84.6% | 40,050 | -78.3% | 0.00% | -80.0% |
| Q1 2022 | $13,418,000 | -31.5% | 184,647 | +11.5% | 0.01% | -16.7% |
| Q4 2021 | $19,582,000 | -15.4% | 165,614 | -4.0% | 0.01% | -33.3% |
| Q3 2021 | $23,149,000 | -75.7% | 172,561 | -70.7% | 0.01% | -75.7% |
| Q2 2021 | $95,236,000 | +475.5% | 588,199 | +185.3% | 0.04% | +362.5% |
| Q1 2021 | $16,547,000 | -6.1% | 206,177 | -36.4% | 0.01% | -11.1% |
| Q4 2020 | $17,625,000 | +2693.2% | 324,011 | +920.1% | 0.01% | – |
| Q3 2020 | $631,000 | -66.8% | 31,762 | -64.9% | 0.00% | -100.0% |
| Q2 2020 | $1,902,000 | – | 90,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |